Colchicine does not lower uric acid. It is purely an anti-inflammatory medication that reduces the pain and swelling of gout attacks, but it has zero effect on the amount of uric acid circulating in your blood. This is one of the most common points of confusion about gout treatment, because colchicine is so closely associated with the disease that many people assume it targets the root cause.
What Colchicine Actually Does
Colchicine works by disrupting the internal scaffolding of white blood cells, specifically neutrophils, which are the immune cells that swarm uric acid crystals in your joints and trigger intense inflammation. It binds to a structural protein called tubulin, preventing cells from assembling the tiny tubes they need to move, communicate, and release inflammatory chemicals. The result is that fewer immune cells migrate to the affected joint, and those that do arrive are less able to amplify the inflammatory response.
This means colchicine addresses the consequence of uric acid crystals (inflammation and pain) without doing anything about the crystals themselves or the uric acid that formed them. Your serum uric acid level before and after taking colchicine will be essentially the same.
At a more granular level, colchicine also blocks a key immune sensor called the NALP3 inflammasome, which is the molecular alarm system that detects urate crystals and kicks off the production of powerful inflammatory signals. By shutting down this alarm, colchicine interrupts the cascade before it fully develops. Pain relief typically begins within 24 hours of taking it, and clinical trials measure treatment success as a 50% or greater reduction in pain within 32 to 36 hours.
Why Colchicine Is Paired With Uric Acid Drugs
If colchicine doesn’t lower uric acid, you might wonder why doctors prescribe it alongside drugs that do. The answer involves a frustrating paradox: starting a uric acid-lowering medication like allopurinol or febuxostat often triggers new gout flares, sometimes worse than what you were experiencing before treatment.
This happens because dropping your uric acid level causes existing crystal deposits in your joints and tissues to dissolve and shift around. That remodeling process irritates the joint lining and provokes the same inflammatory response as a fresh attack. Colchicine acts as a shield during this vulnerable period, keeping inflammation in check while the real work of lowering uric acid takes place in the background.
American College of Rheumatology guidelines recommend continuing this protective colchicine therapy for at least 3 to 6 months after starting a uric acid-lowering drug. If you have no visible tophi (hard uric acid lumps under the skin), prophylaxis can stop 3 months after reaching your target uric acid level. If you previously had tophi that have since resolved, prophylaxis should continue for 6 months after hitting that target.
Drugs That Actually Lower Uric Acid
The medications that reduce uric acid work through entirely different mechanisms than colchicine. They fall into two main categories. The first group, which includes allopurinol and febuxostat, blocks the enzyme your body uses to produce uric acid in the first place. Less production means lower blood levels over time. The second group, which includes probenecid, helps your kidneys excrete more uric acid into your urine. A third option, pegloticase, is an injectable enzyme that breaks down uric acid directly and is reserved for severe cases that don’t respond to oral medications.
Colchicine plays no role in any of these pathways. Think of it this way: uric acid-lowering drugs fix the plumbing, while colchicine mops up the flood damage.
Side Effects to Know About
Colchicine’s most common side effect is diarrhea, reported by about 18% of users compared to 13% of people taking a placebo. Other gastrointestinal symptoms like nausea and cramping fall into the same range. These effects are thought to stem from increased intestinal motility and fluid secretion triggered by the drug.
Colchicine also has a narrow safety margin, meaning the gap between an effective dose and a harmful one is relatively small. This makes drug interactions particularly dangerous. Certain medications dramatically increase colchicine levels in the blood by blocking the liver enzymes and transport proteins that clear it from your system. The antibiotic clarithromycin, for example, can increase colchicine blood concentration by 230% and extend its half-life from 9 hours to 30 hours. Other high-risk combinations include the heart medications diltiazem and verapamil, antifungals like ketoconazole and itraconazole, the HIV drug ritonavir, and the immunosuppressant cyclosporine. Co-administration of cyclosporine with colchicine has been linked to fatal cases of severe muscle breakdown.
The Bottom Line on Uric Acid
Colchicine is an essential part of gout management, but it manages symptoms, not the underlying disease. If your uric acid levels are consistently elevated (above 6 mg/dL is the typical treatment target), you need a separate medication specifically designed to bring that number down. Colchicine keeps you comfortable while that process unfolds, and it can cut short an acute flare when one breaks through, but it will never move the needle on your uric acid level itself.